CollaGenex Pharmaceuticals is Awarded $962,000 NIH Grant to Support Research of Potent Anti-Inflammatory Effects of Incyclinide
14-Nov-2005 -
CollaGenex Pharmaceuticals, Inc. announced that the National Institutes of Health ("NIH") has awarded a grant of approximately $962,000 for additional research into the potent anti-inflammatory effects of incyclinide (formerly known as Col-3), the Company's compound currently in Phase II clinical ...
acne
clinical trials
inflammation